Advanced Search

Technical Analysis for GTH - Genetron Holdings Limited

Grade Last Price % Change Price Change
grade B 13.78 5.67% 0.74
GTH closed up 5.67 percent on Friday, July 10, 2020, on 56 percent of normal volume.
3 Watchers
Watchlist Portfolio

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A Up
Historical GTH trend table...
Date Alert Name Type % Chg
180 Bullish Setup Bullish Swing Setup 0.00%
Hot IPO Pullback Bullish Swing Setup 0.00%
NR7 Range Contraction 16.39%
NR7-2 Range Contraction 16.39%
Inside Day Range Contraction 16.39%
Hot IPO Pullback Bullish Swing Setup 14.17%
NR7 Range Contraction 14.17%
Inside Day Range Contraction 14.17%
New 52 Week Closing Low Bearish 22.05%
New 52 Week Low Weakness 22.05%
Older EOD signals for GTH ...
View Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Read My Charts!
Configure default chart indicators Basic chart:

Profile

Genetron Holdings Limited is a leading precision oncology platform company in China that specializes in cancer molecular profiling and harnesses advanced technologies in molecular biology and data science to transform cancer treatment. The Company has developed a comprehensive product and service portfolio that cover the full-cycle of cancer care from early screening, to diagnosis and treatment recommendations, to continuous monitoring and continuous care.
Cancer Oncology Cancer Treatment Precision Medicine Cancer Care Systems Biology

Is GTH a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Counts: 1 bullish, 0 bearish and 4 neutral indicators. You may wish to incorporate that into your trading strategies.

Recent News

Date Title
Jun 30 Genetron Health Presents Cancer Clinical Research Data at AACR Virtual Annual Meeting Highlighting the Sensitivity and Specificity of its NGS Technology in Precision Oncology
Jun 30 The Daily Biotech Pulse: Verrica Flags Potential Regulatory Delay, Back-To-Back FDA Approvals For Merck's Keytruda, OncoCyte Stalls Lung Nodule Malignancy Test
Jun 25 The Daily Biotech Pulse: Merck's Wonder Cancer Drug Snags Another Approval, Decision Day For Zogenix, UniQure Out-Licenses Gene Therapy
Jun 24 The Daily Biotech Pulse: MediciNova On Track For European Patent Win, Partial Clinical Hold Lifted For Innate Pharma, Tela Bio Details Coronavirus Impact
Jun 23 The Daily Biotech Pulse: Sanofi Expedites COVID-19 Vaccine Timeline, Apyx Cleared For Market Expansion, Miragen's Positive Readout
Jun 19 Genetron prices upsized IPO at $16, trading kicks off today
Jun 19 Genetron Health Announces Pricing of Initial Public Offering
Jun 16 IPO Update: Genetron Holdings Files Proposed IPO Terms
See more GTH news...

Indicators

Indicator Value
52 Week High 17.71
52 Week Low 11.09
Average Volume 867,324
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 0.00
10-Day Moving Average 12.94
Average True Range 1.37
ADX 0.0
+DI 11.51
-DI 29.30
Chandelier Exit (Long, 3 ATRs ) 13.61
Chandelier Exit (Short, 3 ATRs ) 15.19
Upper Bollinger Band 0.00
Lower Bollinger Band 0.00
Percent B (%b) 0.0
BandWidth 0.00
MACD Line 0.06
MACD Signal Line 0.03
MACD Histogram 0.0284
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 15.57
Resistance 3 (R3) 15.39 14.63 15.27
Resistance 2 (R2) 14.63 14.17 14.71 15.17
Resistance 1 (R1) 14.20 13.89 14.42 14.38 15.07
Pivot Point 13.44 13.44 13.54 13.52 13.44
Support 1 (S1) 13.01 12.98 13.23 13.19 12.49
Support 2 (S2) 12.25 12.70 12.33 12.39
Support 3 (S3) 11.82 12.25 12.29
Support 4 (S4) 12.00